Higher Risk of Poor Clinical Outcomes in Female Hypertrophic Cardiomyopathy Patients Compared to Male Counterparts

https://pubmed.ncbi.nlm.nih.gov/38116536

Female patients with hypertrophic cardiomyopathy (HCM) have a higher risk of poor clinical outcomes, including all-cause mortality and composite endpoints, compared to male patients with HCM.